Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 257,889 | 293,182 | 212,499 | 374,330 | 80,366 |
| Cost of Goods | 63,157 | 51,226 | 38,090 | 10,480 | 13,535 |
| Gross Profit | 194,732 | 241,956 | 174,409 | 363,850 | 66,831 |
| Operating Expenses | 468,143 | 474,723 | 502,962 | 343,824 | 188,435 |
| Operating Income | -273,255 | -232,541 | -328,463 | 20,506 | -121,069 |
| Interest Expense | 153,663 | 174,790 | 214,681 | 109,906 | 2,545 |
| Other Income | 220,282 | 425,790 | -156,128 | 115,092 | 4,312 |
| Pre-tax Income | -206,636 | 18,459 | -699,272 | 25,693 | -119,303 |
| Income Tax | -1,286 | 177,614 | -90,615 | -86,128 | -3,927 |
| Net Income Continuous | -205,349 | -159,155 | -608,658 | 111,820 | -115,376 |
| Net Income | $-205,349 | $-159,155 | $-608,658 | $111,820 | $-115,376 |
| EPS Basic Total Ops | -1.50 | -1.16 | -4.55 | 0.86 | -0.91 |
| EPS Basic Continuous Ops | -1.50 | -1.16 | -4.56 | 0.86 | -0.91 |
| EPS Diluted Total Ops | -1.50 | -1.16 | -4.55 | 0.85 | -0.91 |
| EPS Diluted Continuous Ops | -1.50 | -1.16 | -4.56 | 0.84 | -0.91 |
| EPS Diluted Before Non-Recurring Items | -1.50 | -1.16 | -4.56 | 0.85 | -0.91 |
| EBITDA(a) | $-261,852 | $-221,441 | $-316,524 | $30,021 | $-114,075 |